aifollow.news
返回 IT之家 科技新闻
IT之家 科技新闻· · 原发布时间 AI 评分53

Isomorphic Labs 完成 50 亿美元 C 轮融资

AI 辅助摘要

Alphabet 旗下药物研发 AI 企业 Isomorphic Labs 宣布完成 50 亿美元 C 轮融资,由 Greenoaks 和 Sequoia Capital 共同领投。公司计划将资金用于推进基础模拟模型、扩大内部及合作药物候选项目规模,并建设全球 AI 驱动的生物工程基础设施。

正文 · AI 翻译

IT Home reported on November 17 that Isomorphic Labs, an Alphabet subsidiary developing drugs with AI and led by Nobel laureate Demis Hassabis, announced today local time that it had completed a Series C funding round totaling $5 billion (IT Home note: approximately 33.396 billion yuan at the current exchange rate).

The round was co-led by Greenoaks and Sequoia Capital, with new investors including a16z (Andreessen Horowitz) joining. Alphabet continued to invest substantial funds, while existing investors including Thrive Capital, MGX, GV, CapitalG, Temasek, and the UK Sovereign AI Fund also participated.

Isomorphic Labs plans to use the funds to continue developing foundational simulation models, expand the scale of its internal and partnered drug candidate programs, and build global AI-driven bioengineering infrastructure.

发现内容有误?提交纠错